Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
about
Vaccine prevention of maternal cytomegalovirus infectionCytomegalovirus infection in transplant recipientsClinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationReal-time PCR in clinical microbiology: applications for routine laboratory testing.Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South AfricaA prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantationCMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature.Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsOccult cytomegalovirus in vivarium-housed mice may influence transplant allograft acceptance.Clinical utility of droplet digital PCR for human cytomegalovirusEtanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.Emerging technologies for the clinical microbiology laboratory.Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.Reduced mortality after allogeneic hematopoietic-cell transplantation.Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment.Seroprevalence of Cytomegalovirus among pregnant women and hospitalized children in PalestineShedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India.Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxisCongenital cytomegalovirus infection in pediatric hearing lossIntensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipientsModeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ cultureEpstein-barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis.Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus InfectionValganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialCoreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.Cytomegalovirus in hematopoietic stem cell transplant recipientsReduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation PracticesClinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.Clinical significance of low cytomegalovirus DNA levels in human plasma.Cytomegalovirus Reinfections Stimulate CD8 T-Memory InflationTNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant RecipientsSafety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.Viral diagnostics in the era of digital polymerase chain reaction.Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi.
P2860
Q24645631-9F5428CC-6E91-463B-8594-58D61BD2BB7BQ26801802-B744D8BD-F66D-4108-8E4C-40FF0A38C3A4Q26826856-30BD8CB7-BA42-48F7-86FD-0AD799A0E58AQ27472851-BCE24498-86E2-4BD3-B4BD-31A4B92CE71EQ28743974-F977919A-DEE7-4676-9660-CB3D20258CFDQ33264234-11AC030E-5468-4439-831D-AA104C52B700Q33390694-B506E089-0A1E-4FCB-BF69-F23D3D97D64FQ33396929-281FA393-0501-4558-8E5C-0D07FD727144Q33678775-A146E63D-BCAF-41AD-8844-A4FEB1F72E05Q33828598-8FE6F81C-ABC2-4C1D-BC72-BCC40D0C059DQ33932079-BAE5FFA4-E6C7-4EEB-9059-DCBB86719045Q33945476-C3389DE5-CFD3-401F-9C11-FE6D2E8C3358Q34058634-A5DCC800-F412-49BB-AC20-6F52B8080C9FQ34093615-F46DEEC1-F51C-49A5-B87A-0B9C7D5FA125Q34297668-2E218AFB-302A-454E-9EF2-23E1FD80C4FAQ34455315-D1E0DC57-5A89-4411-BC91-4797CEBEA7B6Q34472861-661F477A-2523-4DEE-A2F1-24A75CD7B332Q34742654-CF3A803C-A11D-4D06-9AF3-A5E33EBD1DD2Q35037239-C3E107ED-491A-4783-819C-FADB9E516724Q35140202-F5448231-F4FF-49B8-AF5D-285ABDCA08FCQ35140692-182F3967-568A-484A-BEC4-720777122FDFQ35190208-22A9D6FE-027F-4ECB-BA98-3E4CE6478EF4Q35553386-7C39F51D-BC75-4351-B00D-1259BE23CD85Q35599273-06428686-4677-414A-8F4C-848D96F17F04Q35623744-55D2D52E-FC45-4420-9C7B-2FD04BEF8AD7Q35661025-D7769482-22B8-4213-B1AC-A9530AF77E63Q35683719-A6FAA628-8779-474C-911A-1E15D7907DC7Q35735525-38B26AE0-BB78-40B6-A510-24BC9D7AEAF2Q35752239-8E45F6BB-1BA0-44DD-BDA5-79C5CD618ADBQ35922928-CFF7E5DE-1EAA-42E5-908F-1595D8B55C91Q35975542-75CEF144-B4D0-4F3D-998B-0ECE589D2D69Q36095851-77B01745-F5D5-4BDB-B477-F90BFD63313DQ36118750-8C07E509-3076-4DB5-90CA-96B6C053CB3BQ36199934-2D58F0FA-88AA-41DE-B9B5-D56B5D08E9EDQ36236659-5D84F3D9-F641-4585-B65D-8ABDF6762B60Q36306393-DD0BA6CB-2D14-49FD-925A-FD3CA318DE4DQ36389162-41B47C89-03E8-4F15-B1D6-BE7F89D4E7B5Q36430938-210217CB-8587-4584-B626-34E92C966DECQ36460329-8AACC3E2-99F7-4773-9A73-489D8C28E5BEQ36592679-B8B282DD-2701-4F78-83C9-5E361C7FC418
P2860
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@ast
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@en
type
label
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@ast
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@en
prefLabel
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@ast
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@en
P2093
P2860
P1476
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
@en
P2093
James Ferrenberg
Laurence Stensland
MeeiLi Huang
Terry Stevens-Ayers
W Garrett Nichols
P2860
P304
P356
10.1128/JCM.42.3.1142-1148.2004
P407
P577
2004-03-01T00:00:00Z